TP53 pathway analysis in paediatric Burkitt lymphoma reveals increased MDM4 expression as the only TP53 pathway abnormality detected in a subset of cases-Reference-Cited by-同舟云学术

TP53 pathway analysis in paediatric Burkitt lymphoma reveals increased MDM4 expression as the only TP53 pathway abnormality detected in a subset of cases

Published:2012-07-27 Issue:6 Volume:158 Page:763-771
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Leventaki Vasiliki¹,Rodic Vladimir¹,Tripp Sheryl R.²,Bayerl Michael G.³,Perkins Sherrie L.,Barnette Phillip⁴,Schiffman Joshua D.,Miles Rodney R.

Affiliation:

1. Department of Pathology; University of Utah Health Sciences Center; Salt Lake City; UT; USA

2. ARUP Laboratories Institute for Clinical and Experimental Pathology; Salt Lake City; UT; USA

3. Department of Pathology; Penn State College of Medicine; Hershey; PA; USA

4. Department of Pediatric Hematology/Oncology; University of Utah; Salt Lake City; UT; USA

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2012.09243.x/fullpdf

Reference42 articles.

1. Significance of HDMX-S (or MDM4) mRNA splice variant overexpression and HDMX gene amplification on primary soft tissue sarcoma prognosis;Bartel;International Journal of Cancer,2005

2. The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors;Bhatia;Cancer Research,1992

3. MDM4 (MDMX) is overexpressed in chronic lymphocytic leukaemia (CLL) and marks a subset of p53wild-type CLL with a poor cytotoxic response to Nutlin-3;Bo;British Journal of Haematology,2010

4. Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate (‘Orange’) in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report;Cairo;Leukemia,2002

5. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents;Cairo;Blood,2007

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prognostic value of <i>TP53</i> mutational status in children with Burkitt lymphoma treated according to the B-NHL-2010M protocol;Pediatric Hematology/Oncology and Immunopathology;2024-01-23

2. MDMX in Cancer: A Partner of p53 and a p53-Independent Effector;Biologics: Targets and Therapy;2024-01

3. Translocation Tales: Unraveling the MYC Deregulation in Burkitt Lymphoma for Innovative Therapeutic Strategies;Lymphatics;2023-07-11

4. Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes;PLOS ONE;2021-05-04

5. MDMX/MDM4 is highly expressed and contributes to cell growth and survival in anaplastic large cell lymphoma;Leukemia & Lymphoma;2021-02-11